HDAC1 and diffuse large B-cell lymphoma: We selected Chidamide, a specific inhibitor of Class I and II HDACs, including HDAC1, HDAC2, HDAC3, and HDAC10, which showed a significant association with DLBCL in our bioinformatic analyses.